What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Jashvant D. Unadkat mainly focuses on Pharmacology, Pharmacokinetics, Transporter, Biochemistry and Abcg2.
His work in the fields of Drug overlaps with other areas such as Nelfinavir.
Jashvant D. Unadkat has researched Pharmacokinetics in several fields, including Pregnancy, Anesthesia and Ciclosporin.
His Transporter study combines topics from a wide range of disciplines, such as Transport protein, In vitro and In vivo.
His study looks at the intersection of Biochemistry and topics like Chromatography with Troleandomycin, Dextromethorphan, Furafylline and Sulfaphenazole.
His Abcg2 study incorporates themes from Endocrinology, Placenta, Fetus, Internal medicine and Tissue expression.
His most cited work include:
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update (287 citations)
- Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography. (230 citations)
- Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. (199 citations)
What are the main themes of his work throughout his whole career to date?
Jashvant D. Unadkat focuses on Pharmacology, Pharmacokinetics, Transporter, Internal medicine and In vivo.
His research integrates issues of Efflux and CYP3A in his study of Pharmacology.
His research in Pharmacokinetics tackles topics such as Pregnancy which are related to areas like Physiology.
His Transporter research is classified as research in Biochemistry.
As a part of the same scientific study, Jashvant D. Unadkat usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Fetus, Placenta, Abcg2 and Cystic fibrosis.
His Drug course of study focuses on Distribution and Blood–brain barrier and P-glycoprotein.
He most often published in these fields:
- Pharmacology (46.10%)
- Pharmacokinetics (30.86%)
- Transporter (24.16%)
What were the highlights of his more recent work (between 2017-2021)?
- Transporter (24.16%)
- Pharmacology (46.10%)
- In vivo (18.22%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Transporter, Pharmacology, In vivo, Drug and Pharmacokinetics.
Transporter is a primary field of his research addressed under Biochemistry.
His work carried out in the field of Pharmacology brings together such families of science as Efflux and Cannabinoid.
His In vivo research incorporates themes from Cell culture, Cell, In vitro, Hepatocyte and Quantitative proteomics.
His Drug research includes elements of Computational biology and Hepatic clearance.
Jashvant D. Unadkat combines subjects such as Risk analysis and Prescription drug with his study of Pharmacokinetics.
Between 2017 and 2021, his most popular works were:
- Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance (72 citations)
- Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches (48 citations)
- Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper (31 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Transporter, Pharmacology, In vivo, Organic anion transporter 1 and Drug are his primary areas of study.
Jashvant D. Unadkat interconnects Molecular biology, Nephrotoxicity and Aquaporin in the investigation of issues within Transporter.
His Pharmacology study combines topics in areas such as Efflux and Quantitative proteomics.
His In vivo research is multidisciplinary, incorporating elements of Biotinylation and Physiologically based pharmacokinetic modelling.
The study of Drug is intertwined with the study of Pharmacokinetics in a number of ways.
His research ties Internal medicine and Endocrinology together.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
